1. Home
  2. DCO vs SUPN Comparison

DCO vs SUPN Comparison

Compare DCO & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ducommun Incorporated

DCO

Ducommun Incorporated

HOLD

Current Price

$182.16

Market Cap

2.9B

Sector

Industrials

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$45.27

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCO
SUPN
Founded
1849
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
1995
2010

Fundamental Metrics

Financial Performance
Metric
DCO
SUPN
Price
$182.16
$45.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$153.60
$61.60
AVG Volume (30 Days)
203.6K
935.2K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.95
N/A
Revenue
$824,730,000.00
$392,755,000.00
Revenue This Year
$7.40
$22.70
Revenue Next Year
$8.59
$19.14
P/E Ratio
$93.01
N/A
Revenue Growth
4.85
N/A
52 Week Low
$84.76
$42.45
52 Week High
$210.39
$59.68

Technical Indicators

Market Signals
Indicator
DCO
SUPN
Relative Strength Index (RSI) 45.10 42.17
Support Level $165.13 $44.07
Resistance Level $209.83 $46.79
Average True Range (ATR) 6.73 1.37
MACD -2.96 -0.28
Stochastic Oscillator 8.44 16.53

Price Performance

Historical Comparison
DCO
SUPN

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers, and manufactures various sizes of complex contoured aerostructure components and assemblies, and supplies composite and metal-bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets, including A&D and Industrial end-use markets. It generates a maximum of its revenue from the Electronic Systems.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: